Purchase Order 75N95021P00194
Award Date 4/26/21
Potential Completion Date 7/25/21
Potential Value $107K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a for-profit manufacturer, for the purchase of Simoa 4-plex 96-well plate assays. The assays will be used to investigate biomarkers related to Alzheimer's disease as part of the Baltimore Longitudinal Study of Aging. The potential value of the award is $197,969.40, and the completion date is December 20, 2021. This...
- This firm fixed-price purchase order was awarded by the National Institute on Aging, a civilian agency, to Quanterix Corporation for an assay kit to quantify serum/plasma levels of Abeta40, Abeta 42, GFAP, and NF-light using a Simoa 4-plex assay. The $176,152.50 contract supports research on cognitive resilience and impairment, including for Alzheimer's disease, under the Baltimore Longitudinal Study of Aging. This requirement did not utilize any set-asides. Quanterix, a for-profit manufacturer,...
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
- This is a purchase order awarded by the National Institutes of Health (NIH) National Institute on Aging to Quanterix Corporation, a for-profit life sciences company, for the delivery of Simoa 4-plex assay kits and related materials. The order is valued at $39,428.06 and is for the supply of Neurology 4-Plex E assay kits, Simoa disk kits, and buffer solutions to process tau protein (p-tau 181) assays for the Baltimore Longitudinal Study of Aging (BLSA). The order does not have a set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $180,806 firm-fixed-price purchase order contract to Quanterix Corporation, a life sciences company that provides digital biomarker detection technology. The contract is for a SIMOA HD-X analyzer, which will replace the Institute's aging HD-1 platform and be used by the entire NIA Intramural Research Program. Quanterix has received over $30 million in prior federal contracts from...
- This non-competitive purchase order for $197,979.19 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Aging to Quanterix Corporation of Billerica, Massachusetts. The firm fixed price order is for the purchase of Quanterix assay kits including the Neurology 3-Plex A Advantage Kit, pTau-181 Advantage Kit, P-Tau 231 Simoa Assay Kit, discs, buffers, and sealing oil to be used with the Simoa HD-X Analyzer currently owned by NIA. The...
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
- <p>The National Institute on Aging awarded a purchase order to Quanterix Corporation for $17,000.00 on October 20, 2017, with completion expected November 6, 2018. Work is performed at Baltimore, Maryland. The order is firm fixed price with no set-aside designation. Quanterix supplies ultra-sensitive biomarker detection equipment, assay kits, and reagents to support federal research initiatives.</p>
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $209,479.20 firm fixed-price purchase order to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract is for the delivery of assay kits. Quanterix has previously received over $30 million in federal contracts from agencies including the National Institutes of Health, Department of Veterans Affairs, and...
- <p>The National Institute on Aging awarded a purchase order to Quanterix Corporation valued at $19,089.81 on September 22, 2017, with completion scheduled for October 22, 2017. Work is performed in Baltimore, Maryland. The order is firm fixed price with no small business set-aside. The source does not specify the goods or services procured.</p>